Inovio Pharmaceuticals, Inc. financial data

Symbol
INO on Nasdaq
Industry
Pharmaceutical Preparations
Location
660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
INOVIO BIOMEDICAL CORP (to 5/11/2010), GENETRONICS BIOMEDICAL CORP (to 4/1/2005), GENETRONICS BIOMEDICAL LTD (to 8/3/2001)
Latest financial report
10-K - Q4 2024 - Mar 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 385 % -2.66%
Debt-to-equity 45 % +17.2%
Return On Assets -88.8 % -41.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.7M shares +56.9%
Common Stock, Shares, Outstanding 36.1M shares +58.4%
Entity Public Float 208M USD +73.8%
Common Stock, Value, Issued 36.1K USD +58.4%
Weighted Average Number of Shares Outstanding, Basic 27.2M shares +22.5%
Weighted Average Number of Shares Outstanding, Diluted 27.2M shares +22.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 218K USD -73.8%
Research and Development Expense 75.6M USD -12.8%
General and Administrative Expense 37M USD -22.2%
Operating Income (Loss) -112M USD +21.9%
Net Income (Loss) Attributable to Parent -107M USD +20.6%
Earnings Per Share, Basic -3.95 USD/shares +35.1%
Earnings Per Share, Diluted -3.95 USD/shares +35.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 65.8M USD +360%
Cash, Cash Equivalents, and Short-term Investments 94.1M USD -35.2%
Accounts Receivable, after Allowance for Credit Loss, Current 1.2M USD -50.1%
Assets, Current 97.8M USD -36.1%
Property, Plant and Equipment, Net 3.66M USD -26.2%
Operating Lease, Right-of-Use Asset 8.11M USD -14.5%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 0 USD -100%
Other Assets, Noncurrent 1.98M USD +227%
Assets 113M USD -33.8%
Liabilities, Current 35.3M USD -17%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 9.37M USD -15.1%
Liabilities 44.7M USD -16.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -676K USD -1.97%
Retained Earnings (Accumulated Deficit) -1.73B USD -6.61%
Stockholders' Equity Attributable to Parent 68.5M USD -41.6%
Liabilities and Equity 113M USD -33.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.8M USD +21.6%
Net Cash Provided by (Used in) Financing Activities -11.4M USD -2576%
Net Cash Provided by (Used in) Investing Activities 45.4M USD +139%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 36.1M shares +58.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.29M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 65.8M USD +360%
Interest Paid, Excluding Capitalized Interest, Operating Activities 533K USD +0.06%
Deferred Tax Assets, Valuation Allowance 349M USD +6.64%
Deferred Tax Assets, Gross 351M USD +6.51%
Operating Lease, Liability 11.9M USD -11.7%
Depreciation 424K USD -40%
Payments to Acquire Property, Plant, and Equipment 35.6K USD -88%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -107M USD +20.6%
Lessee, Operating Lease, Liability, to be Paid 14.4M USD -18.3%
Property, Plant and Equipment, Gross 20.1M USD -22%
Operating Lease, Liability, Current 2.5M USD +3.78%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.56M USD +2.57%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.48M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.57M USD -39.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.96M USD -16.9%
Deferred Tax Assets, Operating Loss Carryforwards 250M USD +6.24%
Preferred Stock, Shares Issued 9 shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 24.6M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.31M USD -21.8%
Additional Paid in Capital 1.8B USD +3.36%
Preferred Stock, Shares Outstanding 9 shares 0%
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 1.7M USD -14.5%
Interest Expense 1.09M USD -13.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%